Open AccessA Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis
Author(s) -
Tadao Akizawa,
Yusuke Yamaguchi,
Tetsuro Otsuka,
Michael Reusch
Publication year - 2020
Publication title -
the nephron journals/nephron journals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.951
H-Index - 72
eISSN - 2235-3186
pISSN - 1660-8151
DOI - 10.1159/000508100
Subject(s) - medicine , anemia , kidney disease , discontinuation , transferrin saturation , gastroenterology , tolerability , dialysis , adverse effect , randomized controlled trial , clinical endpoint , surgery , iron deficiency